← Leaderboards
Stuart S Martin
Johns Hopkins University
$11,571,187
Attributed
$13,308,822
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,308,822 · 9
VA$0 · 1
By mechanism
R01$11,742,160 · 3
K01$773,730 · 1
R21$542,552 · 1
P30$196,380 · 3
K12$54,000 · 1
I01$0 · 1
Top collaborators
- Konstantinos Konstantopoulos11 shared
- Giuliano Scarcelli2 shared
- Rebecca G. Nowak1 shared
- Taofeek K Owonikoko1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Viswanathan Natarajan$24,234,784
- Gayle Giboney Page$6,910,993
- Richard E Mains$9,772,587
- Pamela L. Zeitlin$9,680,949
- Eaton E Lattman$1,253,761
Others in their field
Top investigators on “Neoplasm Metastasis”
- Charles A Coltman · Southwest Oncology Group$110,022,912
- Timothy J Eberlein · Washington University$54,581,241
- Samuel A Wells · Duke University$31,864,469
- William George Nelson · Johns Hopkins University$31,104,956
- Zaver M Bhujwalla · Johns Hopkins University$30,433,864
- Leonidas C Platanias · University Of Illinois At Chicago$30,290,986
Research focus
Neoplasm MetastasisTumorImageTissuesAffectCellsNeoplastic CellMolecularDistantMicrotubulesActinsExtracellular MatrixResponseBreast Cancer CellTherapeutic TargetSurfaceTubulinMalignant Breast NeoplasmPharmaceutical PreparationsIn VitroCessation Of LifeCell MotilityNeoplasm Circulating CellsCancer Therapy
Grant awards (59)
The interplay of ion transporters and cytoskeleton in breast cancer migration and metastasis$480,931
R01 · FY2025 · CA
Tubulin microtentacles in detached mammary epithelial cells$424,018
R01 · FY2025 · CA · contact PI
Tubulin microtentacles in detached mammary epithelial cells$86,338
R01 · FY2025 · CA · contact PI
Tubulin microtentacles in detached mammary epithelial cells$65,666
R01 · FY2025 · CA · contact PI
Advancing Oncologic Research Communities in Health Equity (ARCH) K12 Program$54,000
K12 · FY2025 · CA
The interplay of ion transporters and cytoskeleton in breast cancer migration and metastasis$462,178
R01 · FY2024 · CA
Tubulin microtentacles in detached mammary epithelial cells$402,817
R01 · FY2024 · CA · contact PI
Tubulin microtentacles in detached mammary epithelial cells$82,019
R01 · FY2024 · CA · contact PI
The investigation of tubulin microtentacle formation during resurgent breast cancer stem cell differentiation$79,541
R01 · FY2024 · CA · contact PI
Hormone Related Cancers Program$39,587
P30 · FY2024 · CA · contact PI
The interplay of ion transporters and cytoskeleton in breast cancer migration and metastasis$27,223
R01 · FY2024 · CA
Rapid analysis of patient tumor cell drug responses to reduce metastatic risk$0
I01 · FY2024 · VA · contact PI
The interplay of ion transporters and cytoskeleton in breast cancer migration and metastasis$482,102
R01 · FY2023 · CA
Tubulin microtentacles in detached mammary epithelial cells$424,018
R01 · FY2023 · CA · contact PI
Targeting microtubule stabilization to reduce breast tumor metastasis$359,599
R01 · FY2023 · CA · contact PI
Stimulated Brillouin Flow Cytometry for biomechanical assessment of metastatic potential$258,169
R21 · FY2023 · CA
Single cell determination of ROS and calcium roles in breast cancer apoptotic resistance$84,842
R01 · FY2023 · CA · contact PI
The interplay of ion transporters and cytoskeleton in breast cancer migration and metastasis$77,642
R01 · FY2023 · CA
Hormone Related Cancers Program$39,587
P30 · FY2023 · CA · contact PI
Rapid analysis of patient tumor cell drug responses to reduce metastatic risk$0
I01 · FY2023 · VA · contact PI
The interplay of ion transporters and cytoskeleton in breast cancer migration and metastasis$487,296
R01 · FY2022 · CA
Tubulin microtentacles in detached mammary epithelial cells$415,539
R01 · FY2022 · CA · contact PI
Targeting microtubule stabilization to reduce breast tumor metastasis$359,599
R01 · FY2022 · CA · contact PI
Stimulated Brillouin Flow Cytometry for biomechanical assessment of metastatic potential$284,383
R21 · FY2022 · CA
The interplay of ion transporters and cytoskeleton in breast cancer migration and metastasis$77,643
R01 · FY2022 · CA
Hormone Related Cancers Program$39,587
P30 · FY2022 · CA · contact PI
Rapid analysis of patient tumor cell drug responses to reduce metastatic risk$0
I01 · FY2022 · VA · contact PI
The interplay of ion transporters and cytoskeleton in breast cancer migration and metastasis$534,281
R01 · FY2021 · CA
Tubulin microtentacles in detached mammary epithelial cells$437,643
R01 · FY2021 · CA · contact PI
Targeting microtubule stabilization to reduce breast tumor metastasis$366,938
R01 · FY2021 · CA · contact PI
The interplay of ion transporters and cytoskeleton in breast cancer migration and metastasis$50,571
R01 · FY2021 · CA
Hormone Related Cancers Program$39,587
P30 · FY2021 · CA · contact PI
Rapid analysis of patient tumor cell drug responses to reduce metastatic risk$0
I01 · FY2021 · VA · contact PI
Targeting microtubule stabilization to reduce breast tumor metastasis$366,938
R01 · FY2020 · CA · contact PI
Hormone Responsive Cancers (HRC)$38,032
P30 · FY2020 · CA · contact PI
Rapid analysis of patient tumor cell drug responses to reduce metastatic risk$0
I01 · FY2020 · VA · contact PI
Tubulin microtentacles in detached mammary epithelial cells$436,628
R01 · FY2019 · CA · contact PI
Targeting microtubule stabilization to reduce breast tumor metastasis$366,938
R01 · FY2019 · CA · contact PI
Rapid analysis of patient tumor cell drug responses to reduce metastatic risk$0
I01 · FY2019 · VA · contact PI
Tubulin microtentacles in detached mammary epithelial cells$295,632
R01 · FY2018 · CA · contact PI
Tubulin microtentacles in detached mammary epithelial cells$154,500
R01 · FY2018 · CA · contact PI
Tubulin microtentacles in detached mammary epithelial cells$295,632
R01 · FY2017 · CA · contact PI
Targeting microtubule stabilization to reduce breast tumor metastasis$318,513
R01 · FY2016 · CA · contact PI
Tubulin microtentacles in detached mammary epithelial cells$295,632
R01 · FY2016 · CA · contact PI
Targeting microtubule stabilization to reduce breast tumor metastasis$318,513
R01 · FY2015 · CA · contact PI
Tubulin microtentacles in detached mammary epithelial cells$295,632
R01 · FY2015 · CA · contact PI
Targeting microtubule stabilization to reduce breast tumor metastasis$308,957
R01 · FY2014 · CA · contact PI
Targeting microtubule stabilization to reduce breast tumor metastasis$299,402
R01 · FY2013 · CA · contact PI
Targeting microtubule stabilization to reduce breast tumor metastasis$318,513
R01 · FY2012 · CA · contact PI
Stabilized microtubule protrusions in detached mammary epithelial cells$273,686
R01 · FY2011 · CA · contact PI
Stabilized microtubule protrusions in detached mammary epithelial cells$282,150
R01 · FY2010 · CA · contact PI
Stabilized microtubule protrusions in detached mammary epithelial cells$282,150
R01 · FY2009 · CA · contact PI
Stabilized microtubule protrusions in detached mammary epithelial cells$282,150
R01 · FY2008 · CA · contact PI
Stabilized microtubule protrusions in detached mammary epithelial cells$282,150
R01 · FY2007 · CA · contact PI
Actin-regulated Apoptosis in Mammary Tumorigenesis$161,730
K01 · FY2007 · CA · contact PI
Actin-regulated Apoptosis in Mammary Tumorigenesis$161,730
K01 · FY2006 · CA · contact PI
Actin-regulated Apoptosis in Mammary Tumorigenesis$161,730
K01 · FY2005 · CA
Actin-regulated Apoptosis in Mammary Tumorigenesis$159,810
K01 · FY2004 · CA
Actin-regulated Apoptosis in Mammary Tumorigenesis$128,730
K01 · FY2003 · CA